Vasoconstrictor Agents
Research News and Information

Sunday, November 22, 2009

A hemodynamic profile for consciousness during cardiopulmonary resuscitation.

30 Oct 2009 We report the quantification of a hemodynamic profile sufficient to support consciousness during cardiopulmonary resuscitation. A 62-yr-old man experienced cardiac arrest while being evaluated for heart failure after heart transplantation. During ... Read more...

Terlipressin: a promising vasoactive agent in hemodynamic support of septic shock.

29 Sep 2009 BACKGROUND: At present, terlipressin is predominantly used for the management of bleeding gastric and esophageal varices, as well as hepato-renal syndrome secondary to liver cirrhosis. Owing to its high and relatively selective affinity to vascular ... Read more...

Predictors of 30-day mortality in patients with refractory cardiogenic shock following acute myocardial infarction despite a patent infarct artery.

29 Sep 2009 BACKGROUND: Little is known about predictors of survival in patients with persistent shock following acute myocardial infarction (MI) despite a patent infarct artery. METHODS: We examined data from TRIUMPH, a multicenter randomized clinical trial of ... Read more...

Latest indexed articles for 'Vasoconstrictor Agents'

These are the very latest articles for this heading:

• A hemodynamic profile for consciousness during cardiopulmonary resuscitation. 30 Oct 2009
• Unpublished clinical trials with sumatriptan. 29 Oct 2009
• Terlipressin: a promising vasoactive agent in hemodynamic support of septic shock. 29 Sep 2009
• Predictors of 30-day mortality in patients with refractory cardiogenic shock following acute myocardial infarction despite a patent infarct artery. 29 Sep 2009
• Local anesthesia using buffered 0.5% lidocaine with 1:200,000 epinephrine for tumors of the digits treated with Mohs micrographic surgery. 29 Sep 2009
• Altered reactivity to norepinephrine through COX-2 induction by vascular injury in hypercholesterolemic rabbits. 23 Sep 2009
• Renal failure in cirrhosis. 22 Sep 2009
• siRNA-mediated knockdown of h-caldesmon in vascular smooth muscle. 16 Sep 2009
• [Cocaine-triggered ischaemic enteritis] 12 Sep 2009
• Absence of adenosine-mediated aortic relaxation in A(2A) adenosine receptor knockout mice. 9 Sep 2009
• Impaired function of coronary BK(Ca) channels in metabolic syndrome. 9 Sep 2009
• [Importance of drug treatment to lower portal pressure in the therapy of variceal bleeding] 31 Aug 2009
• A prospective, randomized, double-blind comparison of 2% lidocaine with 1:100,000 and 1:50,000 epinephrine and 3% mepivacaine for maxillary infiltrations. 30 Aug 2009
• Pulmonary arterial hypertension in human immunodeficiency virus infection. 30 Aug 2009
• Determination of 8-epi PGF(2alpha) concentrations as a biomarker of oxidative stress using triple-stage liquid chromatography/tandem mass spectrometry. 30 Aug 2009
• The effect of angiotensin-converting enzyme inhibitor on hemodynamic instability in patients undergoing cardiopulmonary bypass: results of a dose-comparison study. 30 Aug 2009
• Terlipressin vs. octreotide in bleeding esophageal varices. 30 Aug 2009
• The management of severe sepsis and septic shock. 30 Aug 2009
• Vasopressin attenuates TNF-mediated inflammation in the rat cremaster microcirculation. 30 Aug 2009
• Prevention of early variceal rebleeding adding banding to terlipressin therapy. 30 Aug 2009

See a longer list of these articles.

Technical information about 'Vasoconstrictor Agents'

Definition: Drugs used to cause constriction of the blood vessels.

Registry Number: 0

Descriptor UI: D014662

Alternative terms: Vasoconstrictor Agents; Agents, Vasoconstrictor; Vasoconstrictor Drugs; Drugs, Vasoconstrictor; Vasoconstrictors; Vasoactive Agonists; Agonists, Vasoactive; Vasopressor Agents; Agents, Vasopressor;

Allowable Qualifiers: administration & dosage; adverse effects; analysis; antagonists & inhibitors; blood; cerebrospinal fluid; chemical synthesis; classification; diagnostic use; economics; history; immunology; isolation & purification; metabolism; pharmacokinetics; pharmacology; poisoning; radiation effects; standards; supply & distribution; therapeutic use; toxicity; urine; chemistry; contraindications;

Tree Number: D27.505.954.411.793;

History Note: 67(65)

Technical Notes: consider also VASOMOTOR SYSTEM /drug eff